Sorting and Manipulation of Human PGC-LC Using PDPN and Hanging Drop Cultures

Cells. 2022 Nov 29;11(23):3832. doi: 10.3390/cells11233832.

Abstract

The generation of oocytes from induced pluripotent stem cells (iPSCs) was proven efficient with mouse cells. However, no human iPSCs have yet been reported to generate cells able to complete oogenesis. Additionally, efficient sorting of human Primordial Germ Cell-like Cells (hPGC-LCs) without genomic integration of fluorescent reporter for their downstream manipulation is still lacking. Here, we aimed to develop a model that allows human germ cell differentiation in vitro in order to study the developing human germline. The hPGC-LCs specified from two iPS cell lines were sorted and manipulated using the PDPN surface marker without genetic modification. hPGC-LCs obtained remain arrested at early stages of maturation and no further differentiation nor meiotic onset occurred when these were cultured with human or mouse fetal ovarian somatic cells. However, when cultured independently of somatic ovarian cells, using BMP4 and the hanging drop-transferred EBs system, early hPGC-LCs further differentiate efficiently and express late PGC (DDX4) and meiotic gene markers, although no SYCP3 protein was detected. Altogether, we characterized a tool to sort hPGC-LCs and an efficient in vitro differentiation system to obtain pre-meiotic germ cell-like cells without using a gonadal niche.

Keywords: Induced pluripotent stem cells; human germline; meiotic commitment; primordial germ cells.

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Line
  • Female
  • Germ Cells* / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Membrane Glycoproteins / metabolism
  • Mice
  • Oocytes

Substances

  • PDPN protein, human
  • Membrane Glycoproteins

Grants and funding

This research was funded by Institut Universitaire de France (GL), Electricité de France, Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (BODY EST-2017-43/2) and Université Paris Cité. B.A. holds a fellowship from DIM Biothérapies Région Ile de France (DIMBIO 2014, #14011253).